Niagen Bioscience, Inc. (NAGE) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts NAGE Hot Sheet
Join SI Premium – FREE
Niagen Bioscience, Inc. (NASDAQ: NAGE) reported Q2 EPS of $0.04, $0.02 better than the analyst estimate of $0.02. Revenue for the quarter came in at $31.1 million versus the consensus estimate of $28.36 million.
For earnings history and earnings-related data on Niagen Bioscience, Inc. (NAGE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Reinstates Zoom Video (ZM) at Buy
- Weibo (WB) Tops Q2 EPS by 2c
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
